Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization

American Journal of Bioethics 20 (9):4-17 (2020)
  Copy   BIBTEX


Allocating access to unapproved COVID-19 drugs available via Pre-Approval Access pathways or Emergency Use Authorization raises unique challenges at the intersection of clinical care and research....



    Upload a copy of this work     Papers currently archived: 86,273

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

COVID-19 and Health-Related Authority Allocation Puzzles.Michael da Silva - 2021 - Cambridge Quarterly of Healthcare Ethics 30 (1):25-36.
Medical research in clinical emergency settings in Europe.S. Lotjonen - 2002 - Journal of Medical Ethics 28 (3):183-187.


Added to PP

19 (#653,965)

6 months
5 (#191,274)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Jamie Webb
University of Sussex at Brighton

References found in this work

Principles of biomedical ethics.Tom L. Beauchamp - 1979 - New York: Oxford University Press. Edited by James F. Childress.
Null. Null - 2016 - Philosophy Study 6 (9).

View all 12 references / Add more references